Jeffrey Borer

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Karl Swedberg, Michel Komajda, Michael Böhm et al. · The Lancet · 2010 · 2.6K citations · Full text

Medicine, Cardiology, Pharmacology +11

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

James H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · Circulation · 1987 · 2.3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Targeted Anticytokine Therapy in Patients With Chronic Heart Failure

Douglas L. Mann, John J.V. McMurray, Milton Packer et al. · Circulation · 2004 · 1.2K citations

Medicine, Cardiology, Pharmacology +15

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

Michael Böhm, Karl Swedberg, Michel Komajda et al. · The Lancet · 2010 · 1.1K citations

Medicine, Cardiology, Clinical Cardiology +13

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

William B. White, Kenneth G. Saag, Michael A. Becker et al. · New England Journal of Medicine · 2018 · 891 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16